2m 2m 2m 2m 2m 2m 2m
AQUESTIVE THERP (AQST)
NASDAQ
$3.95+$0.02 (+0.51%)
Price as of Jun 03, 2026 5:35 PM EDT- $504.3MMarket Cap
- 23.58%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AQUESTIVE THERP (AQST)
$3.95+$0.02 (+0.51%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 44.5M -22.61% | 57.6M +13.80% | 50.6M +6.09% | 47.7M -6.20% | |
Cost of Revenue | 18.6M +3.82% | 17.9M -14.20% | 20.8M N/A | N/A N/A | |
Gross Profit | 26.0M -34.52% | 39.7M +33.40% | 29.8M -37.60% | 47.7M -6.20% | |
Sales and Marketing Expense | 79.8M +59.13% | 50.2M +58.05% | 31.8M -39.96% | 52.9M -1.11% | |
Research and Development Expense | -17.2M -15.23% | -20.3M +54.76% | -13.1M -25.04% | -17.5M +2.55% | |
Depreciation and Amortization Expense | 548,000 -23.68% | 718,000 -46.62% | 1.3M -43.65% | 2.4M -19.47% | |
Total Operating Expenses | 115.6M +30.87% | 88.3M +34.48% | 65.7M -26.81% | 89.7M +4.95% | |
Operating Profit | -71.1M +130.90% | -30.8M +103.75% | -15.1M -64.10% | -42.1M +21.30% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | 99,000 -76.60% | |
Interest Expense | N/A N/A | N/A N/A | -6.3M -3.28% | -6.6M -34.80% | |
Interest Income and Expense and Net | 0 N/A | 0 +100.00% | -6.3M -1.80% | -6.5M -32.96% | |
Total Nonoperating Income and Expense | -12.7M -4.84% | -13.4M -311.14% | 6.3M -3.28% | 6.6M -34.80% | |
Income before Taxes | -83.8M +89.77% | -44.2M +479.03% | -7.6M -85.99% | -54.4M -22.87% | |
Income Taxes | 0 +100.00% | -14,000 -105.71% | 245,000 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -83.8M +89.83% | -44.1M +460.83% | -7.9M -85.54% | -54.4M -22.87% | |
Net Income from Continuing Operations Applicable to Common | -83.8M +89.77% | -44.2M +479.03% | -7.6M -85.99% | -54.4M -22.87% | |
Basic EPS and Net Income | -0.78 +52.94% | -0.51 +292.31% | -0.13 -88.39% | -1.12 -39.46% | |
Diluted EPS and Net Income | -0.78 +52.94% | -0.51 +292.31% | -0.13 -88.39% | -1.12 -39.46% | |
Basic Weighted Average Shares | 106.9M +23.29% | 86.7M +41.58% | 61.3M +25.69% | 48.7M +27.99% | |
Diluted Weighted Average Shares | 106.9M +23.29% | 86.7M +41.58% | 61.3M +25.69% | 48.7M +27.99% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 121.2M +69.36% | 71.5M +199.71% | 23.9M -12.47% | 27.3M -2.68% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 121.2M +69.36% | 71.5M +199.71% | 23.9M -12.47% | 27.3M -2.68% | |
Total Current Assets | 149.3M +69.20% | 88.2M +115.35% | 41.0M +2.70% | 39.9M -15.60% | |
Accumulated Depreciation | 44.0M +1.20% | 43.5M +1.44% | 42.9M +2.19% | 42.0M +5.28% | |
Property and Plant and Equipment and Net | 3.9M +2.47% | 3.8M -9.09% | 4.2M +2.30% | 4.1M -19.19% | |
Total Long-Term Assets | 2.6M -37.44% | 4.2M -22.34% | 5.4M -15.70% | 6.5M -6.55% | |
Total Assets | 160.4M +58.17% | 101.4M +76.64% | 57.4M +0.61% | 57.1M -7.94% | |
Income Taxes Payable | 349,000 -4.38% | 365,000 +8.31% | 337,000 +4.66% | 322,000 -7.74% | |
Total Short-Term Debt | 10.0M +38,338.46% | 26,000 +18.18% | 22,000 -99.88% | 18.7M +823.46% | |
Total Current Liabilities | 47.6M +152.36% | 18.9M +3.04% | 18.3M -53.68% | 39.5M +79.97% | |
Total Long-Term Debt | 27.5M -15.33% | 32.5M +18.15% | 27.5M -17.76% | 33.4M -35.12% | |
Total Long-Term Liabilities | 7.3M +203.51% | 2.4M +18.80% | 2.0M -0.88% | 2.0M -18.15% | |
Total Liabilities | 194.1M +20.12% | 161.6M -1.42% | 163.9M -6.67% | 175.6M +21.85% | |
Retained Earnings | -447.0M +23.07% | -363.2M +13.83% | -319.1M +2.53% | -311.2M +21.19% | |
Total Stockholders Equity | -33.7M -44.04% | -60.2M -43.51% | -106.5M -10.18% | -118.6M +44.34% | |
Total Shares Outstanding | 122.0M +33.51% | 91.4M +33.39% | 68.5M +25.00% | 54.8M +32.98% | |
Cash Flow | |||||
Cash from Operating Activities | -52.4M +46.63% | -35.8M +460.49% | -6.4M -34.82% | -9.8M -70.32% | |
Capital Expenditures | 562,000 +253.46% | 159,000 -84.02% | 995,000 -2.83% | 1.0M +12.16% | |
Cash from Investing Activities | -562,000 +253.46% | -159,000 -84.02% | -995,000 -60.58% | -2.5M +176.45% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 102.6M +22.76% | 83.6M +2,003.47% | 4.0M -65.63% | 11.6M -61.60% | |
Financials Ratio | |||||
Gross Margin | 58.35% -15.38% | 68.95% +17.23% | 58.82% N/A | N/A N/A | |
Operating Margin | -159.50% +198.37% | -53.46% +79.05% | -29.86% -66.16% | -88.23% +29.32% | |
Return on Assets | -63.99% +15.15% | -55.57% +304.22% | -13.75% -84.96% | -91.40% -19.10% | |
Return on Equity | 178.61% +237.18% | 52.97% +657.36% | 6.99% -87.10% | 54.22% -49.79% | |
Revenue Growth | -22.61% -263.92% | 13.80% +126.58% | 6.09% +198.19% | -6.20% -157.05% | |
Current Ratio | 3.14 -32.95% | 4.68 +108.99% | 2.24 +121.74% | 1.01 -53.10% | |
Cash Ratio | 2.55 -32.89% | 3.79 +190.86% | 1.30 +88.97% | 0.69 -45.92% | |
Debt-to-Equity Ratio | -1.11 +106.10% | -0.54 +109.17% | -0.26 -41.24% | -0.44 -32.56% | |
Debt-to-Assets Ratio | 0.23 -27.10% | 0.32 -33.12% | 0.48 -47.53% | 0.91 +5.74% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow